Synthesis, characterization, and biocompatibility of alternating block polyurethanes based on PLA and PEG

One-Pot Reactive Melt Recycling of PLA Post-Consumer Waste for the Production of Block Copolymer Nanocomposites of High Strength and Ductility

Post-consumer waste recycling is a crucial issue for building a sustainable society. However, mechanical recycling of poly(lactic acid) (PLA) often reduces the performance of the recycled material because PLA has a strong tendency to degrade during reprocessing. Therefore, it is of great interest to develop an effective recycling method to improve the mechanical performance of this material. This paper presents a one-pot melt process for turning PLA waste into a biodegradable block copolymer and its high strength and ductility composite. The process was conducted in a melt-mixer through a transesterification of PLA with poly(ethylene glycol) (PEG) or poly(propylene glycol) (PPG) as a soft component and clay as reinforcement. Effects of soft component content and sequence of clay addition on the mechanical performance of the prepared materials were focused. The results showed the successful preparation of PLA-based multiblock copolymers of high molecular weights (~100 kDa). Both virgin PLA and recycled source could serve as the starting material. PEG was more efficient than PPG in providing an intense improvement of PLA ductility. The nanocomposite of intercalated structure yielded nearly 100 times higher elongation at break (E_b = 506%) than the starting PLA (E_b = 5.6%) with high strength of 39.5 MPa and modulus of 1.4 GPa, considering the advantages of clay addition. Furthermore, the products with a broadened range of properties can be designed based on the ratio of PLA and soft component, as well as the organization and spatial distribution of clay in the copolymer matrices.

Relationship and improvement strategies between drug nanocarrier characteristics and hemocompatibility: What can we learn from the literature

This article discusses the various blood interactions that may occur with various types of nano drug-loading systems. Nanoparticles enter the blood circulation as foreign objects. On the one hand, they may cause a series of inflammatory reactions and immune reactions, resulting in the rapid elimination of immune cells and the reticuloendothelial system, affecting their durability in the blood circulation. On the other hand, the premise of the drug-carrying system to play a therapeutic role depends on whether they cause coagulation and platelet activation, the absence of hemolysis and the elimination of immune cells. For different forms of nano drug-carrying systems, we can find the characteristics, elements and coping strategies of adverse blood reactions that we can find in previous researches. These adverse reactions may include destruction of blood cells, abnormal coagulation system, abnormal effects of plasma proteins, abnormal blood cell behavior, adverse immune and inflammatory reactions, and excessive vascular stimulation. In order to provide help for future research and formulation work on the blood compatibility of nano drug carriers.

Synthesis of PLA-poly(ether urethane)-PLA copolymers and design of biodegradable anti-adhesive membranes for orthopaedic applications

Peritendinous adhesions cause chronic pain and disability. Leading causes are trauma to tendons and surrounding tissues and immobilization after surgery. Adhesions occur between 24 hours to 6 weeks after surgery. Anti-adhesion barriers are currently the best option available to prevent peritendinous adhesions, but are ineffective and difficult to use. We developed an anti-adhesive membrane that can be easily applied during tendon surgery and effectively prevent adhesions. The membrane is based on a new triblock copolymer, is non-toxic, can be bio-eliminated, and has a degradation rate of more than 6 weeks for optimal anti-adhesion effect. We synthesized and characterized poly(ether urethane) (PEU) from poly(ethylene glycol). Triblock copolymers poly(lactic acid)-PEU-poly(lactic acid) (PLA-PEU-PLA) were then synthesized from PEU with PLA blocks of different lengths, and characterized. The membranes were shaped by hot molding and their mechanical properties, contact angle, water uptake, the kinetics of in vitro degradation and cytotoxicity were studied. Mechanical properties were developed according to the needs of orthopaedic surgeons. Results showed that membranes maintained their filmogenic integrity, have a degradation rate for optimal adhesion prevention, can be bioeliminated and biocompatible suggesting that they could be safely and effectively used as anti-adhesion orthopaedic devices. These results support the use of PLA-PEU-PLA membranes as a medical device, however, the effectiveness of the membranes in vivo needs to be further evaluated. A future study using an in vivo rat model of postoperative peritendinous adhesions is currently being developed.

Long-term glycemic control and prevention of diabetes complications in vivo using oleic acid-grafted-chitosan‑zinc-insulin complexes incorporated in thermosensitive copolymer

Daily injections for basal insulin therapy are far from ideal resulting in hypo/hyperglycemic episodes associated with fatal complications in type-1 diabetes patients. Here we report a delivery system that provides controlled release of insulin closely mimicking physiological basal insulin requirement for an extended period following a single subcutaneous injection. Stability of insulin was significantly improved by formation of zinc-insulin hexamers, further stabilized by electrostatic complex formation with chitosan polymer. Insulin complexes were homogenously incorporated into PLA-PEG-PLA, a biodegradable thermogel copolymer, that instantaneously forms a subcutaneous gel-depot following injection. Chitosan polymer was hydrophobically modified using oleic acid prior to complex formation with insulin to enable distribution of oleic acid-grafted-chitosan‑zinc-insulin complexes into the hydrophobic core of PLA-PEG-PLA thermogel-copolymer micelles. In vivo, daily administration of marketed long-acting insulin, glargine, resulted in fluctuating blood glucose levels between 91 and 443 mg/dL in type 1 diabetic rats. However, single administration of thermogel copolymeric formulation successfully demonstrated slow diffusion of insulin complexes maintaining peak-free basal insulin level of 21 mU/L for 91 days. Sustained release of basal insulin also correlated with efficient glycemic control (blood glucose <120 mg/dL), prevention of diabetic ketoacidosis and absence of cataract development, unlike other treatment groups. Moreover, there was no sign of inflammation, tissue damage, or collagen deposition around depot site, suggesting exceptional biocompatibility of the formulation for long-term use.

Smart Thermosensitive Copolymer Incorporating Chitosan-Zinc-Insulin Electrostatic Complexes for Controlled Delivery of Insulin: Effect of Chitosan Chain Length

This work was designed to optimize thermosensitive copolymeric depot-based system for delivering insulin at a controlled rate for a prolonged period following a single subcutaneous injection. Intrinsic ability of insulin to form hexamers in the presence of zinc and electrostatic complexes with chitosan (CS) were explored for improving stability and release characteristics of insulin through the copolymeric depot. CS-zinc-insulin complexes were prepared using CS of different chain lengths (5, 30, 50, 200 kDa). Effect of different chain lengths of CS on the thermal stability, binding constant, and release profile of insulin was determined. Increasing chain length of CS demonstrated increasing thermal stability of insulin. However, higher chain length of CS adversely affected the release profile of insulin. Hydrolytic degradation analysis showed rapid degradation of copolymer in formulation containing higher chain length of CS (200 kDa)-zinc-insulin complexes, implying formation of bigger pores and channels in copolymeric matrix during initial release in this system. However, formulation containing smaller chain length of CS (5 kDa)-zinc-insulin complexes demonstrated slow copolymer degradation and sustained insulin release profile. Additionally, CS-zinc-insulin complexes were effective in preserving stability of insulin during the entire duration of release and storage.

Synthesis, Characterization, and Bacterial Fouling-Resistance Properties of Polyethylene Glycol-Grafted Polyurethane Elastomers

Despite advances in material sciences and clinical procedures for surgical hygiene, medical device implantation still exposes patients to the risk of developing local or systemic infections. The development of efficacious antimicrobial/antifouling materials may help with addressing such an issue. In this framework, polyethylene glycol (PEG)-grafted segmented polyurethanes were synthesized, physico-chemically characterized, and evaluated with respect to their bacterial fouling-resistance properties. PEG grafting significantly altered the polymer bulk and surface properties. Specifically, the PEG-grafted polyurethanes possessed a more pronounced hard/soft phase segregated microstructure, which contributed to improving the mechanical resistance of the polymers. The better flexibility of the soft phase in the PEG-functionalized polyurethanes compared to the pristine polyurethane (PU) was presumably also responsible for the higher ability of the polymer to uptake water. Additionally, dynamic contact angle measurements evidenced phenomena of surface reorganization of the PEG-functionalized polyurethanes, presumably involving the exposition of the polar PEG chains towards water. As a consequence, Staphylococcus epidermidis initial adhesion onto the surface of the PEG-functionalized PU was essentially inhibited. That was not true for the pristine PU. Biofilm formation was also strongly reduced.

Drug-Polymer Interaction, Pharmacokinetics and Antitumor Effect of PEG-PLA/Taxane Derivative TM-2 Micelles for Intravenous Drug Delivery

PURPOSE

A novel polymer micelle was prepared with a high drug loading, good stability, high tolerance and better anti-tumor effect.

METHODS

TM-2 was encapsulated in poly-block-poly (D, L-lactic acid) self-assembled micelles by the thin-film hydration method. From the critical micelle concentrations of the copolymers, particle size, drug loading and encapsulation efficiency of drug-loading micelles, the appropriate polymer material could be assessed. Comparisons between TM-2 solution and TM-2 micelles were done to evaluate the pharmacokinetics and toxicity in rats, compared with Taxol to evaluate the anti-tumor effect in mice.

RESULTS

The optimized TM-2 micelles achieved a high drug loading (~20%) with the polymer material of PEG_2k-PLA_2.5k, with a particle size of 30 nm and no significant change in particle size after lyophilization. The result of pharmacokinetic experiment displayed that the half-life in vivo was obviously prolonged. The maximum tolerated dose of TM-2 micelles was approximately 25 mg/kg in rats, and the relative tumor growth rate of Taxol (15 mg/kg), TM-2 (10 mg/kg), TM-2 (15 mg/kg) and TM-2 (40 mg/kg) in mice were 49.35%, 49.14%, 36.44 and 9.98% respectively.

CONCLUSIONS

TM-2 micelles with high drug loading increased drug solubility, improved tolerance, antitumor effects and reduced toxicity.

Developing chemoselective and biodegradable polyester elastomers for bioscaffold application

Thermal polyesterification has emerged as a successful method for synthesizing polyesters for biomedical applications. However, to date, no general functionalization strategy has been incorporated into materials designed by the thermal polycondensation of polyacids and polyols. Herein, we report the design of several elastomers based on the thermal polycondensation of 4-ketopimelic acid, citric acid, and one of two diols: 1,6-hexanediol or 1,4-cyclohexanedimethanol. By varying the diol and the curing conditions, several elastomers were designed with a range of physical and mechanical properties. Poly(diol 4-ketopimelate-co-diol citrate) achieved Young's modulus, ultimate tensile stress, and rupture strain values of 0.39-1.13 MPa, 0.27-1.04 MPa, and 108-426%, respectively. Additionally, the incorporation of the ketone from 4-ketopimelic acid gave these materials two advantageous characteristics: a site for covalent functionalization through oxime formation and the ability to covalently bond to the surrounding tissue through imine linkages. Biocompatibility was studied both in vitro and in vivo in order to gain a complete understanding as to how biological systems respond to these novel materials. Based on preliminary results, we believe that poly(diol 4-ketopimelate-co-diol citrate) polyketoesters are excellent candidates for biomaterials.